Ruximera Trademark Details

This mark is alive with a status of First Extension - Granted. The last case file activity for this mark occured 7 years ago on Thursday, June 30, 2016, according to the United State Patent & Trademark Office
Word Mark Ruximera
Status Alive 730 — First Extension - Granted
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Serial Number 86692269
Status Date Thursday, June 30, 2016
Filing Date Thursday, June 30, 2016
Attorney Katrina Edge

Correspondent

KATRINA EDGE
Pfizer Inc
235 E 42nd St
New York, NY 10017-5703

Case File Statements

Goods & Services Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Friday, July 17, 2015
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.